125 related articles for article (PubMed ID: 8499409)
21. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations.
Humphries SE; Cook M; Dubowitz M; Stirling Y; Meade TW
Lancet; 1987 Jun; 1(8548):1452-5. PubMed ID: 2885451
[TBL] [Abstract][Full Text] [Related]
22. Characterization of polymorphic structure of cathepsin G gene: role in cardiovascular and cerebrovascular diseases.
Herrmann SM; Funke-Kaiser H; Schmidt-Petersen K; Nicaud V; Gautier-Bertrand M; Evans A; Kee F; Arveiler D; Morrison C; Orzechowski HD; Elbaz A; Amarenco P; Cambien F; Paul M
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1538-43. PubMed ID: 11557685
[TBL] [Abstract][Full Text] [Related]
23. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.
Scarabin PY; Arveiler D; Amouyel P; Dos Santos C; Evans A; Luc G; Ferrières J; Juhan-Vague I;
Atherosclerosis; 2003 Jan; 166(1):103-9. PubMed ID: 12482556
[TBL] [Abstract][Full Text] [Related]
24. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
Brazier L; Tiret L; Luc G; Arveiler D; Ruidavets JB; Evans A; Chapman J; Cambien F; Thillet J
Atherosclerosis; 1999 Jun; 144(2):323-33. PubMed ID: 10407493
[TBL] [Abstract][Full Text] [Related]
25. G-455A polymorphism of beta-fibrinogen gene and the risk of premature myocardial infarction in Greece.
Rallidis LS; Gialeraki A; Fountoulaki K; Politou M; Sourides V; Travlou A; Lekakis I; Kremastinos DT
Thromb Res; 2010 Jan; 125(1):34-7. PubMed ID: 19409601
[TBL] [Abstract][Full Text] [Related]
26. Genetic factors determining thrombosis and fibrinolysis.
Humphries SE; Green FR; Temple A; Dawson S; Henney A; Kelleher CH; Wilkes H; Meade TW; Wiman B; Hamsten A
Ann Epidemiol; 1992 Jul; 2(4):371-85. PubMed ID: 1342288
[TBL] [Abstract][Full Text] [Related]
27. Beta-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes.
Lam KS; Ma OC; Wat NM; Chan LC; Janus ED
Diabetologia; 1999 Oct; 42(10):1250-3. PubMed ID: 10525668
[TBL] [Abstract][Full Text] [Related]
28. Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.
Carter AM; Ossei-Gerning N; Wilson IJ; Grant PJ
Circulation; 1997 Sep; 96(5):1424-31. PubMed ID: 9315527
[TBL] [Abstract][Full Text] [Related]
29. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).
Koster T; Rosendaal FR; Reitsma PH; van der Velden PA; Briët E; Vandenbroucke JP
Thromb Haemost; 1994 Jun; 71(6):719-22. PubMed ID: 7974338
[TBL] [Abstract][Full Text] [Related]
30. [beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients].
Liu Y; Pan J; Wang S
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):336-8. PubMed ID: 11798781
[TBL] [Abstract][Full Text] [Related]
31. Fibrinogen genotype and risk of peripheral atherosclerosis.
Fowkes FG; Connor JM; Smith FB; Wood J; Donnan PT; Lowe GD
Lancet; 1992 Mar; 339(8795):693-6. PubMed ID: 1347581
[TBL] [Abstract][Full Text] [Related]
32. The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration.
Mannila MN; Eriksson P; Leander K; Wiman B; de Faire U; Hamsten A; Silveira A
J Intern Med; 2007 Feb; 261(2):138-47. PubMed ID: 17241179
[TBL] [Abstract][Full Text] [Related]
33. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
Samani NJ; O'Toole L; Martin D; Rai H; Fletcher S; Lodwick D; Thompson JR; Morice AH; Channer K; Woods KL
J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
[TBL] [Abstract][Full Text] [Related]
34. The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden.
Green F; Hamsten A; Blombäck M; Humphries S
Thromb Haemost; 1993 Dec; 70(6):915-20. PubMed ID: 8165611
[TBL] [Abstract][Full Text] [Related]
35. Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance.
Niskanen L; Schwab US; Sarkkinen ES; Krusius T; Vahtera E; Uusitupa MI
Metabolism; 1997 Jun; 46(6):666-72. PubMed ID: 9186303
[TBL] [Abstract][Full Text] [Related]
36. Association of genetic variants of hemostatic genes with myocardial infarction in Egyptian patients.
El-Fattah AAA; Sadik NAH; Sedrak H; Battah A; Nabil M
Gene; 2018 Jan; 641():212-219. PubMed ID: 29054763
[TBL] [Abstract][Full Text] [Related]
37. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction.
Cambien F; Costerousse O; Tiret L; Poirier O; Lecerf L; Gonzales MF; Evans A; Arveiler D; Cambou JP; Luc G
Circulation; 1994 Aug; 90(2):669-76. PubMed ID: 8044936
[TBL] [Abstract][Full Text] [Related]
38. Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators.
Sentí M; Aubó C; Bosch M; Pavesi M; Pena A; Masiá R; Marrugat J
Clin Biochem; 1998 Nov; 31(8):647-51. PubMed ID: 9876897
[TBL] [Abstract][Full Text] [Related]
39. A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction.
Yu Q; Safavi F; Roberts R; Marian AJ
J Investig Med; 1996 Apr; 44(4):154-9. PubMed ID: 8689411
[TBL] [Abstract][Full Text] [Related]
40. Fibrinogen B beta polymorphisms do not directly contribute to an altered in vitro clot structure in humans.
Maghzal GJ; Brennan SO; George PM
Thromb Haemost; 2003 Dec; 90(6):1021-8. PubMed ID: 14652632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
